Views & Analysis An innovative approach to improving research and patient car... Understanding how patients are treated in routine clinical care has great potential to improve treatment and enrich academic research.
News Pharma welcomes dialogue with politicians ahead of election Conservative and Labour politicians assure industry with warm words at conference.
News NHS faces a "Mission Impossible", say hospitals Leaders must take action to prevent longer waits for ops and A&E treatment.
News Prime minister accused of being "in denial" about NHS crisis PM under fire over A&E waiting times.
News Government in denial over NHS funding, say MPs No 10 under fire over health funding from Public Accounts Committee.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends